AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2018
Sep 6, 2018
30786_dirs_2018-09-06_f56467f5-291f-4171-96d2-94f0e9595e39.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-09-04
Reporting Person: HUTTON RONALD W (Vice President and Treasurer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-09-04 | Restricted Stock Units | $0 | A | 900 | Acquired | Bio-Rad A Common Stock (900) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 3477.6236 | Direct |
Footnotes
F1: Includes 7.9680, 6.8111, 7.3343 and 6.3192 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 9/30/17, 12/29/17, 3/29/18 and 6/29/18, respectively.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13